{"AllianceGenome": "2640", "HGNC": "2640", "MIM": "605340", "_id": "1551", "_version": 1, "accession": {"genomic": ["AC069294.5", "AF280107.1", "CH236956.1", "CH471091.2", "CP068271.2", "KF454904.1", "KF459646.1", "NC_000007.14", "NC_060931.1", "NG_007983.1"], "protein": ["AAG32289.1", "AAH67436.1", "BAA00310.1", "EAL23867.1", "EAW76637.1", "NP_000756.3", "P24462.3"], "rna": ["BC067436.1", "BC069780.1", "BX643367.1", "BX647143.1", "D00408.1", "NM_000765.5"], "translation": [{"protein": "NP_000756.3", "rna": "NM_000765.5"}, {"protein": "AAH67436.1", "rna": "BC067436.1"}, {"protein": "BAA00310.1", "rna": "D00408.1"}]}, "alias": ["CP37", "CYPIIIA7", "P-450(HFL33)", "P-450111A7", "P450-HFLA", "P450HLp2"], "ec": "1.14.14.1", "ensembl": {"gene": "ENSG00000160870", "protein": "ENSP00000337450", "transcript": ["ENST00000336374", "ENST00000467776", "ENST00000477357", "ENST00000498080"], "translation": [{"protein": "ENSP00000337450", "rna": "ENST00000336374"}], "type_of_gene": "protein_coding"}, "entrezgene": "1551", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 19.12685776, "exp_mis": 155.3207613, "exp_syn": 62.066695, "lof_z": 1.3877323127759, "mis_z": -0.301382239074596, "mu_lof": 1.20726855386e-06, "mu_mis": 1.32276921463e-05, "mu_syn": 4.99712271642e-06, "n_lof": 13.0, "n_mis": 163.0, "n_syn": 57.0, "p_li": 2.92836029852247e-07, "p_null": 0.246557714809935, "p_rec": 0.753441992354036, "syn_z": 0.398699181448175}, "bp": 1512, "cds_end": 99332716, "cds_start": 99303122, "n_exons": 13, "nonpsych": {"exp_lof": 17.0433892, "exp_mis": 140.3120184, "exp_syn": 55.9080865, "lof_z": 1.437654557165, "mis_z": -0.199619020521955, "mu_lof": 1.20726855386e-06, "mu_mis": 1.32276921463e-05, "mu_syn": 4.99712271642e-06, "n_lof": 11.0, "n_mis": 145.0, "n_syn": 52.0, "p_li": 4.54686098270608e-06, "p_null": 0.177307284307765, "p_rec": 0.822688168831252, "syn_z": 0.329071847476887}, "nontcga": {"exp_lof": 17.57056104, "exp_mis": 142.8689617, "exp_syn": 57.07521403, "lof_z": 1.31095389799854, "mis_z": -0.297230683924466, "mu_lof": 1.20726855386e-06, "mu_mis": 1.32276921463e-05, "mu_syn": 4.99712271642e-06, "n_lof": 12.0, "n_mis": 150.0, "n_syn": 52.0, "p_li": 8.8547672865011e-07, "p_null": 0.247520296886688, "p_rec": 0.752478817636584, "syn_z": 0.425355996269417}, "transcript": "ENST00000336374.2"}, "exons": [{"cdsend": 99735093, "cdsstart": 99705499, "chr": "7", "position": [[99705035, 99705595], [99707811, 99707974], [99709034, 99709261], [99710731, 99710892], [99713468, 99713535], [99714554, 99714682], [99715757, 99715906], [99717176, 99717265], [99717525, 99717639], [99720312, 99720412], [99722295, 99722348], [99731058, 99731152], [99735022, 99735196]], "strand": -1, "transcript": "NM_000765", "txend": 99735196, "txstart": 99705035}], "exons_hg19": [{"cdsend": 99332716, "cdsstart": 99303122, "chr": "7", "position": [[99302658, 99303218], [99305434, 99305597], [99306657, 99306884], [99308354, 99308515], [99311091, 99311158], [99312177, 99312305], [99313380, 99313529], [99314799, 99314888], [99315148, 99315262], [99317935, 99318035], [99319918, 99319971], [99328681, 99328775], [99332645, 99332819]], "strand": -1, "transcript": "NM_000765", "txend": 99332819, "txstart": 99302658}], "generif": [{"pubmed": 11940601, "text": "presence of the ER6 motif of CYP3A4 mediates the high expression of CYP3A7 in subjects carrying CYP3A7*1C allele"}, {"pubmed": 12485945, "text": "Expression of CYP3A7 in the endometrium is significantly greater in the proliferative phase compared with the secretory phase of the menstrual cycle."}, {"pubmed": 15937338, "text": "A novel mechanism, consisting of the splicing of the pseudogene CYP3AP1 to CYP3A7, causes the formation of the novel CYP3A7.1L"}, {"pubmed": 15985487, "text": "CYP3A7*1C polymorphism causes the persistence of enzymatic activity of CYP3A7 during adult life, resulting in lower circulating DHEAS and estrone levels."}, {"pubmed": 15985487, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16041241, "text": "analysis of CYP3A7 protein expression in adult human livers"}, {"pubmed": 17334880, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17334880, "text": "the CYP3A7*1C polymorphism might have an influence on bone mass at the lumbar spine independently of serum DHEAS concentrations"}, {"pubmed": 17559345, "text": "Genetic polymorphisms in the CYP3A7 gene in the Han, She and Dong populations may contribute to interindividual differences in metabolic clearance of CYP3A7 substrates."}, {"pubmed": 17559345, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17582393, "text": "Differences in CYP3A41G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 different Chinese ethnic groups; close linkage is demonstrated"}, {"pubmed": 17604264, "text": "CYP3A7 polymorphism might have an influence on bone mass at the lumbar spine independently of serum dehydroepiandrosterone sulphate concentrations."}, {"pubmed": 17604264, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17885626, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18445661, "text": "Adult expression of CYP3A7 may modify the polycystic ovary syndrome phenotype by ameliorating adrenal androgen excess."}, {"pubmed": 18445661, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18978522, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19064572, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19343046, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19424794, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19585271, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19585271, "text": "The genetic variations of CYP3A7 in a Korean population, were analyzed."}, {"pubmed": 19593168, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19801957, "text": "The single nucleotide polymorphism P450 oxidoreductase*28 seems to be a better genetic marker of the variability of total CYP3A activity in vivo than CYP3A4, CYP3A5 and CYP3A7 genetic variants."}, {"pubmed": 19842932, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20118548, "text": "The expression level of CYP3A7 messenger RNA is highest in chorion/decidua at a level which is about 3-fold of placenta and amnion, with the metabolic function to protect the fetus from exposure to drugs."}, {"pubmed": 20147896, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20345875, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20345875, "text": "There were no statistically significant differences in the distribution of CYP3A7 polymorphic alleles between testicular cancer cases and controls suggesting no contribution to individual susceptibility to testicular cancer."}, {"pubmed": 20529763, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20615193, "text": "Recombinant CYP3A4, CYP3A5 and CYP3A7 metabolized R- and S-warfarin to 10- and 4'-hydroxywarfarin with efficiencies that depended on the individual enzymes."}, {"pubmed": 20621111, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20637317, "text": "Data show that both isoforms of CYP3A7 did not metabolize the anti-cancer drug sorafenib, and suggest that CYP3A7 activity does not influence the effectiveness of this anti-cancer drug against HCC."}, {"pubmed": 22253426, "text": "Expression and regulation of human fetal-specific CYP3A7 in mice"}, {"pubmed": 22277676, "text": "Report distinctive response patterns of HIF-1alpha, CYP3A4 and CYP3A7 to cobalt chloride in human fetal liver cells."}, {"pubmed": 23143891, "text": "Report CYP3A7 metabolism of inhaled glucocorticoids."}, {"pubmed": 24168324, "text": "Only CYP1A1, CYP1B1, CYP3A4, CYP3A5 and CYP3A7 expressed in lymphocytes and monocytes."}, {"pubmed": 25689036, "text": "Differences in the expression of nuclear receptors might determine the variability in CYP3A4 and CYP3A7 expression observed in foetal liver."}, {"pubmed": 26238215, "text": "CYP3A4, CYP3A7, UGT2B11 and UGT2B15 genes are significantly downregulated in melanosis coli."}, {"pubmed": 26772622, "text": "Methylation status of cytosine in the CYP3A7 proximal promoter correlated with changes in developmental expression of mRNA."}, {"pubmed": 26921389, "text": "Occupancy by modified histones was consistent with chromatin structural changes contributing to the mechanisms regulating CYP3A7 ontogeny."}, {"pubmed": 26964624, "text": "CYP3A7*1C influences outcome are required."}, {"pubmed": 27349315, "text": "These results suggest the existence of a marked inter-individual variability regarding the presence of the isoforms of CYP3A. In addition, since sorafenib is metabolized by CYP3A4, but not by CYP3A7, an overexpression of CYP3A4 may lead to an increase in the degradation of the drug and then to clinical ineffectiveness."}, {"pubmed": 27727071, "text": "data suggested that hepatocyte nuclear factor 4 alpha and glucocorticoid receptor, and epigenetic changes of H3K4me2 and H3K27me3 are associated with the ontogenic expressions of CYP3A4/3A7 in the livers of the Chinese Han population."}, {"pubmed": 28072767, "text": "The CYP3A7*1C allele is associated with a lower urinary estrone levels, a more pronounced reduction in 2-hydroxylation pathway estrone metabolites (EMs) and a lower ratio of 2-hydroxylation:16alpha-hydroxylation EMs in premenopausal women."}, {"pubmed": 28500872, "text": "polymorphisms may modify the response to dietary methylmercury exposure during early life development"}, {"pubmed": 28750898, "text": "All three neonicotinoid pesticides induced the expression of CYP3A7 in H295R cells; induction was reversed by co-treatment of H295R cells with exogenous estriol. CYP3A7 is normally expressed in fetal liver and is a key enzyme involved in estriol synthesis."}, {"pubmed": 28986474, "text": "our data indicate an alternative binding mode for testosterone in CYP3A7 that favors the 2alpha-hydroxylation, suggesting significant structural differences in its active site compared with CYP3A4/5"}, {"pubmed": 30584253, "text": "CYP3A7 rs2257401 is associated with tacrolimus pharmacokinetics in kidney transplantation."}, {"pubmed": 30874620, "text": "Scaling in vitro activity of CYP3A7 suggests human fetal livers do not clear retinoic acid entering from maternal circulation."}, {"pubmed": 30918015, "text": "CYP3A7 showed abnormally elevated activities at 500 and 750 muM."}, {"pubmed": 31445893, "text": "role of CYP3A7 in development, disease, and xenobiotic metaboolism"}, {"pubmed": 32001245, "text": "kcat values, rather than Km values, for 6beta-hydroxylation of three steroid hormones by CYP3A7 are different from those of CYP3A4 and CYP3A5"}, {"pubmed": 32146629, "text": "CYP3A Polymorphism and Chronic Mercury Intoxication."}, {"pubmed": 32499339, "text": "Urinary Bile Acid Profile of Newborns Born by Cesarean Section Is Characterized by Oxidative Metabolism of Primary Bile Acids: Limited Roles of Fetal-Specific CYP3A7 in Cholate Oxidations."}, {"pubmed": 33438174, "text": "Human Fetal Liver Metabolism of Oxycodone Is Mediated by CYP3A7."}, {"pubmed": 33495599, "text": "CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers."}, {"pubmed": 33723203, "text": "Associations Between Cytochrome P450 (CYP) Gene Single-Nucleotide Polymorphisms and Second-to-Fourth Digit Ratio in Chinese University Students."}, {"pubmed": 33866277, "text": "Development of template systems for ligand interactions of CYP3A5 and CYP3A7 and their distinctions from CYP3A4 template."}, {"pubmed": 34688813, "text": "CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation."}, {"pubmed": 34689350, "text": "Allele and genotype frequencies of CYP3A4, CYP3A5, CYP3A7, and GSTP1 gene polymorphisms among mainland Tibetan, Mongolian, Uyghur, and Han Chinese populations."}], "genomic_pos": {"chr": "7", "end": 99735196, "ensemblgene": "ENSG00000160870", "start": 99705036, "strand": -1}, "genomic_pos_hg19": {"chr": "7", "end": 99332819, "start": 99302660, "strand": -1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0002933", "pubmed": 14559847, "qualifier": "involved_in", "term": "lipid hydroxylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006694", "qualifier": "involved_in", "term": "steroid biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006805", "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0008202", "qualifier": "involved_in", "term": "steroid metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008202", "pubmed": 14559847, "qualifier": "involved_in", "term": "steroid metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008210", "pubmed": [12865317, 14559847], "qualifier": "involved_in", "term": "estrogen metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042572", "qualifier": "involved_in", "term": "retinol metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042573", "pubmed": 11093772, "qualifier": "involved_in", "term": "retinoic acid metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0070989", "qualifier": "involved_in", "term": "oxidative demethylation"}], "CC": {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0004497", "qualifier": "enables", "term": "monooxygenase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004497", "qualifier": "enables", "term": "monooxygenase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005506", "qualifier": "enables", "term": "iron ion binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008395", "pubmed": 14559847, "qualifier": "enables", "term": "steroid hydroxylase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008401", "pubmed": 11093772, "qualifier": "enables", "term": "retinoic acid 4-hydroxylase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0019825", "pubmed": 2722762, "qualifier": "enables", "term": "oxygen binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0020037", "qualifier": "enables", "term": "heme binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0050649", "qualifier": "enables", "term": "testosterone 6-beta-hydroxylase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0062183", "qualifier": "enables", "term": "all-trans retinoic acid 18-hydroxylase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0070330", "qualifier": "enables", "term": "aromatase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0101020", "qualifier": "enables", "term": "estrogen 16-alpha-hydroxylase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0101020", "pubmed": 14559847, "qualifier": "enables", "term": "estrogen 16-alpha-hydroxylase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0101021", "pubmed": 12865317, "qualifier": "enables", "term": "estrogen 2-hydroxylase activity"}]}, "homologene": {"genes": [[4530, 4328761], [7955, 553969], [8364, 548503], [8364, 100494419], [9031, 414832], [9606, 1551], [10090, 13113], [10116, 171352]], "id": 133564}, "interpro": [{"desc": "Cytochrome P450", "id": "IPR001128", "short_desc": "Cyt_P450"}, {"desc": "Cytochrome P450, E-class, group II", "id": "IPR002402", "short_desc": "Cyt_P450_E_grp-II"}, {"desc": "Cytochrome P450, E-class, CYP3A", "id": "IPR008072", "short_desc": "Cyt_P450_E_CYP3A"}, {"desc": "Cytochrome P450, conserved site", "id": "IPR017972", "short_desc": "Cyt_P450_CS"}, {"desc": "Cytochrome P450 superfamily", "id": "IPR036396", "short_desc": "Cyt_P450_sf"}], "ipi": "IPI00396632", "map_location": "7q22.1", "name": "cytochrome P450 family 3 subfamily A member 7", "other_names": ["aryl hydrocarbon hydroxylase", "cytochrome P450 3A7", "cytochrome P450, family 3, subfamily A, polypeptide 7", "cytochrome P450, subfamily IIIA, polypeptide 7", "cytochrome P450-HFLA", "flavoprotein-linked monooxygenase", "microsomal monooxygenase", "xenobiotic monooxygenase"], "pantherdb": {"HGNC": "2640", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "3769707", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 10090, "uniprot_kb": "D3Z2W7"}, {"MGI": "3646373", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 10090, "uniprot_kb": "D3YYZ0"}, {"MGI": "1930638", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 10090, "uniprot_kb": "O09158"}, {"RGD": "628709", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 10116, "uniprot_kb": "Q64581"}, {"MGI": "88610", "ortholog_type": "LDO", "panther_family": "PTHR24302", "taxid": 10090, "uniprot_kb": "Q64464"}, {"RGD": "1595919", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 10116, "uniprot_kb": "F7F0U1"}, {"RGD": "708392", "ortholog_type": "LDO", "panther_family": "PTHR24302", "taxid": 10116, "uniprot_kb": "P51538"}, {"Ensembl": "ENSGALG00000004449", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 9031, "uniprot_kb": "F1NT18"}, {"Ensembl": "ENSGALG00000004436", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 9031, "uniprot_kb": "E1BVB6"}, {"ZFIN": "ZDB-GENE-060929-96", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 7955, "uniprot_kb": "F1R2K3"}, {"ZFIN": "ZDB-GENE-041114-102", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 7955, "uniprot_kb": "E7EY99"}, {"ZFIN": "ZDB-GENE-030131-3060", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 7955, "uniprot_kb": "F1QPC1"}, {"ZFIN": "ZDB-GENE-050604-1", "ortholog_type": "O", "panther_family": "PTHR24302", "taxid": 7955, "uniprot_kb": "A0A0R4IQY0"}], "uniprot_kb": "P24462"}, "pathway": {"kegg": [{"id": "hsa00140", "name": "Steroid hormone biosynthesis - Homo sapiens (human)"}, {"id": "hsa00830", "name": "Retinol metabolism - Homo sapiens (human)"}, {"id": "hsa05204", "name": "Chemical carcinogenesis - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-211859", "name": "Biological oxidations"}, {"id": "R-HSA-211897", "name": "Cytochrome P450 - arranged by substrate type"}, {"id": "R-HSA-211945", "name": "Phase I - Functionalization of compounds"}, {"id": "R-HSA-211981", "name": "Xenobiotics"}], "smpdb": [{"id": "SMP00074", "name": "Retinol Metabolism"}, {"id": "SMP00336", "name": "Vitamin A Deficiency"}, {"id": "SMP00408", "name": "Methadone Action Pathway"}, {"id": "SMP00424", "name": "Citalopram Action Pathway"}, {"id": "SMP00624", "name": "Methadone Metabolism Pathway"}, {"id": "SMP00627", "name": "Citalopram Metabolism Pathway"}, {"id": "SMP00634", "name": "Carbamazepine Metabolism Pathway"}, {"id": "SMP00638", "name": "Levomethadyl Acetate Metabolism Pathway"}], "wikipathways": [{"id": "WP2876", "name": "Pregnane X receptor pathway"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP43", "name": "Oxidation by Cytochrome P450"}, {"id": "WP702", "name": "Metapathway biotransformation Phase I and II"}]}, "pdb": "7MK8", "pfam": "PF00067", "pharmgkb": "PA122", "pharos": {"target_id": 9731, "tdl": "Tclin"}, "pir": "JX0062", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF248159", "relationship": "is"}, {"id": "GNF248160", "relationship": "is"}, {"id": "GNF248161", "relationship": "is"}, {"id": "GNF248162", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF081566", "relationship": "is"}, {"id": "GNF081567", "relationship": "is"}, {"id": "GNF081568", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054831", "relationship": "is"}, {"id": "GNF059613", "relationship": "is"}, {"id": "GNF075031", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF063621", "relationship": "is"}, {"id": "GNF063622", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF003246", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094024", "relationship": "is"}, {"id": "GNF133682", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000007.14", "NC_060931.1", "NG_007983.1"], "protein": "NP_000756.3", "rna": "NM_000765.5", "translation": {"protein": "NP_000756.3", "rna": "NM_000765.5"}}, "reporter": {"HG-U133_Plus_2": ["205939_at", "243609_at"], "HG-U95Av2": ["1757_i_at", "1758_r_at", "1759_f_at", "32705_at"], "HG-U95B": "42514_at", "HTA-2_0": "TC07003300.hg.1", "HuEx-1_0": ["3063463", "3063501"], "HuGene-1_1": "8141342"}, "summary": "This gene encodes a member of the cytochrome P450 superfamily of enzymes, which participate in drug metabolism and the synthesis of cholesterol, steroids and other lipids. This enzyme hydroxylates testosterone and dehydroepiandrosterone 3-sulphate, which is involved in the formation of estriol during pregnancy. This gene is part of a cluster of related genes on chromosome 7q21.1. Naturally-occurring readthrough transcription occurs between this gene and the downstream CYP3A51P pseudogene and is represented by GeneID:100861540. [provided by RefSeq, Jan 2015].", "symbol": "CYP3A7", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413884"}, "unigene": "Hs.111944", "uniprot": {"Swiss-Prot": "P24462"}, "wikipedia": {"url_stub": "CYP3A7"}}